Skip to content

PBMs Under Fire, the World Pharmacist Challenge & CRUSH COST | TWIRx

Pharmacy Podcast Network

35m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

This episode of This Week in Pharmacy covers major industry developments, including new Department of Labor regulations requiring PBMs to disclose fees and rebates, and a congressional investigation into retaliatory pharmacy audits. Host Todd Urie and guest Grant Harding, the Pharmacy 50 most influential person for 2025, discuss Harding's social media platform educating consumers on medication costs, his testing of sketchy gas station supplements, and his international pharmacy hobby. Additionally, Dr. Jesse McCullough previews the upcoming World Pharmacist Challenge and reflects on the conclusion of the 31-day challenge.

  • The Department of Labor has finalized regulations forcing PBMs to disclose fees, rebates, and spread pricing to employer health plans. 10:39
  • True personal and professional transformation begins from within by focusing on changing oneself first. 6:49
  • Social media creators can use public recognition from awards to build trust and advocate for positive changes in the profession. 22:10
  • Lab testing of sketchy gas station male enhancement pills frequently reveals unlisted active pharmaceutical ingredients like sildenafil. 26:53

Chapters

  1. 0:04
    Podcast Introduction and Halloween Theme

    Hosts welcome listeners, introduce the show, and set a Halloween tone for the episode.

  2. 2:02
    Meet Dr. Jesse McCullough and 31‑Day Challenge

    Todd introduces Dr. Jesse McCullough, who explains the 31‑Day Challenge for American Pharmacist Month.

  3. 4:08
    World Pharmacist Challenge Announcement

    Dr. McCullough reveals plans to launch a World Pharmacist Challenge, inviting global stories and challenges.

  4. 5:36
    Personal Growth Story: The Unknown Monk

    McCullough shares a motivational story emphasizing self‑change as the foundation for broader impact.

  5. 10:27
    PBMs Forced to Disclose Fees and Retaliation Claims

    Hosts discuss new regulations requiring PBMs to disclose fees and allegations of PBM retaliation against independent pharmacies.

  6. 13:20
    HHS Peptide Enforcement Discretion Policy

    The episode covers HHS’s interim policy on six controversial peptides and its implications for compounding pharmacies.

  7. 15:00
    Curify Labs 3D Printing and Compounding Opportunities

    Hosts highlight Curify Labs’ 3D printing innovations and discuss revenue potential in non‑sterile compounding.

  8. 18:34
    Grant Harding Interview and Pharmacy 50 Influence

    Todd interviews Grant Harding about his Pharmacy 50 win, the power of recognition, and how it drives advocacy.

  9. 29:44
    Pennsylvania Vape Registry Law Explained

    The hosts explain Pennsylvania’s new vape registry law, its approved brands, and age restrictions.

Highlights

  • 5:24

    The Story of the Unknown Monkstory

    Dr. Jesse McCullough shares an allegorical story about how failing to change the world, nation, or town ultimately taught an old man that the only thing he could truly change was himself.

  • 6:59

    Change Yourself Before Changing Othersinsight

    The final challenge of the 31-day series encourages pharmacists to focus on internal improvement, which ripples out to impact teams, organizations, countries, and potentially the world.

  • 10:39

    DOL Targets PBM Fee Transparencydata

    The Department of Labor finalized new rules requiring PBMs to disclose revenue, rebates, and fees to covered employer health plans, drawing pushback from industry trade association PCMA.

  • 11:57

    Investigating Retaliatory Pharmacy Auditsinsight

    House Oversight Chairman James Comer launched an investigation into whether major PBMs weaponized burdensome audits against pharmacies supporting reform legislation.

  • 26:22

    Gas Station Pill Laboratory Testingstory

    Grant Harding explains how testing questionable gas station supplements at a California lab proved that consumers' safety concerns were valid when active ingredients like sildenafil showed up.

Quotes

  • “I want to encourage you to change yourself. And the add‑on to that is don't stop. Don't stop changing. Don't, don't stop improving.”
    Unnamed speaker · 7:54
  • “If PBMs are already transparent, why is revealing their revenue? Why is that such a problem? Why? Why, why, why?”
    Unnamed speaker · 11:11
  • “When you win that award, there's something to that too, Grant.”
    Unnamed speaker · 19:59
  • Independent Pharmacy Cooperative 17:53–18:40

About this episode

October 30, 2026 | Pharmacy Podcast Network Sponsored by CurifyLabs and Independent Pharmacy Cooperative (IPC) Pharmacy benefit managers are facing new scrutiny, controversial peptides are making headlines, and two pharmacy leaders are joining Todd Eury for a special edition of This Week in Pharmacy. This week's episode features the finale of the 31 Day Challenge, an exciting announcement about the upcoming WORLD PHARMACIST CHALLENGE, and an exclusive in-studio interview with the 2025 Pharmacy 50 winner, Dr. Grant Harting, PharmD, founder of CRUSH COST. TWIRx News: The Vox Top 3 1. PBMs Forced to Open Their Books — and They're Fighting Back The Department of Labor has finalized new PBM transparency requirements covering fees, rebates, spread-pricing revenue, and compensation arrangements involving employer health plans. The Pharmaceutical Care Management Association (PCMA) argues that the regulation creates unnecessary burdens, threatens smaller PBMs, and could increase costs. The big question: If PBMs are already transparent, why is additional financial disclosure such a problem? Read PCMA's response 2. HHS Opens the Door to Six Controversial Peptides HHS has announced an interim enforcement-discretion policy involving six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500. The policy could create a pathway for qualifying 503A compounding pharmacies under specific conditions, even as significant questions remain about the safety and efficacy of these non-FDA-approved substances. The big question: Is this progress for personalized medicine or a dangerous leap ahead of clinical evidence? Read the HHS Federal Register notice 3. Congress Investigates Alleged PBM Retaliation Against Independent Pharmacies House Oversight Committee Chairman James Comer is investigating whether CVS Caremark, Express Scripts, and Optum Rx targeted independent pharmacies with burdensome audits after those pharmacies publicly supported PBM reform. One allegation involves a medication costing just 99 cents that reportedly generated hundreds of hours of pharmacy staff work. The investigation is ongoing, and retaliation has not been established. The big question: Are PBM audits protecting the system, or could they be used to intimidate pharmacies advocating for reform? Read the congressional announcement Special Guest: Dr. Jesse McCullough, PharmD The 31 Day Challenge Finale & WORLD PHARMACIST CHALLENGE Announcement Leadership starts with action! Dr. Jesse McCullough, PharmD, CEO of Keystone Pharmacy Insights, returns to TWIRx for the final special feature of the 31 Day Challenge, reflecting on leadership, personal growth, accountability, and the importance of pharmacists stepping beyond their comfort zones.

Transcript

0:00
35:24

5,384 words · 5 speakers

Topics

  • Still
  • Pharmacy 50
  • PBMs
  • 31 day challenge
  • PCMA
  • Pharmacy Podcast Network
  • Wood Cutter
  • Swartz
  • world pharmacist challenge
  • HHS

Page updated · transcript and summary are machine-generated